All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, March 7, 2021
Home » Authors » Alex Ho

Alex Ho

Articles

ARTICLES

China biotechs remain hopeful for HK market amid protests

Oct. 2, 2019
By Elise Mak and Alex Ho
No Comments
SUZHOU, China, and HONG KONG – Despite investor worries over the long-term political and economic stability of Hong Kong after almost four months of social unrest and frequent violent protests, Chinese biotech executives remain optimistic about the outlook for the prospects for the market.
Read More

China biotechs remain hopeful for HK market amid protests

Sep. 26, 2019
By Elise Mak and Alex Ho
No Comments
SUZHOU, China, and HONG KONG – Despite investor worries over the long-term political and economic stability of Hong Kong after almost four months of social unrest and frequent violent protests, Chinese biotech executives remain optimistic about the outlook for the prospects for the market.
Read More

China's new STAR board a boon for companies, but caution is required

Aug. 7, 2019
By Alex Ho
No Comments
HONG KONG – The new Shanghai Stock Exchange's Science and Technology Innovation board, officially launched in late July, marks China's boldest move yet to attract biopharma and technology companies to its often-turbulent financial markets.
Read More

China's new STAR board a boon for companies, but caution is required

Aug. 5, 2019
By Alex Ho
No Comments
HONG KONG – The new Shanghai Stock Exchange's Science and Technology Innovation board, officially launched in late July, marks China's boldest move yet to attract biopharma and technology companies to its often-turbulent financial markets.
Read More

Despite volatile market so far, HKEX still drawing biotechs as Sinomab applies for IPO

July 24, 2019
By Alex Ho
No Comments
HONG KONG – Sinomab Bioscience Ltd., a Hong Kong clinical-stage antibody firm, said its application for a Hong Kong IPO was accepted by the stock exchange, making it the 16th biopharma to submit an application under the new rules of the Hong Kong Exchange (HKEX).
Read More

Despite volatile market so far, HKEX still drawing biotechs as Sinomab applies for IPO

July 23, 2019
By Alex Ho
No Comments
HONG KONG – Sinomab Bioscience Ltd., a Hong Kong clinical-stage antibody firm, said its application for a Hong Kong IPO was accepted by the stock exchange, making it the 16th biopharma to submit an application under the new rules of the Hong Kong Exchange (HKEX).
Read More

Traditional Chinese medicine gains WHO acceptance despite critics citing lack of evidence

June 19, 2019
By Alex Ho
No Comments
The World Health Assembly, a decision-making body of the World Health Organization (WHO), included a chapter on Chinese traditional medicine in the latest version of its influential global compendium for the first time in history.
Read More

Traditional Chinese medicine gains WHO acceptance despite critics citing lack of evidence

June 13, 2019
By Alex Ho
No Comments
The World Health Assembly, a decision-making body of the World Health Organization (WHO), included a chapter on Chinese traditional medicine in the latest version of its influential global compendium for the first time in history.
Read More

Domestic market growth helps Chinese med-tech market's positive performance

May 28, 2019
By Alex Ho and Elise Mak
No Comments

Chinese biopharmas surge, bulls take over the market

April 8, 2019
By Elise Mak and Alex Ho
No Comments
HONG KONG – The biotech sector in greater China ended the financial year on a high note. Companies on the Hong Kong Stock Exchange reported better-than-expected results, including seven pre-revenue startups that went public over the last year, adding to the energy in the biotech space.
Read More
View All Articles by Alex Ho

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 5.
  • Gloved hand places sample tubes in PCR system

    COVID-19 test makers are adapting for variants

    BioWorld MedTech
    As COVID-19 variants have emerged, so have questions about the effectiveness of tests for infection. While the risk of mutations significantly limiting their...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for March 5.
  • Coronavirus vaccine/therapeutics illustration

    Tonix looks to the past for the future of COVID-19 vaccines and testing

    BioWorld MedTech
    Tonix Pharmaceuticals Holding Corp. is looking to lessons from tuberculosis and smallpox to guide its future in infectious diseases. The company is developing an...
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing